STAT3 and Cachexia: Several known STAT3 inhibitors that directly target hyperphosphorylated STAT3 also reduced markers of cachexia in cell culture models and antagonized catabolic signaling in mice, supporting the concept that STAT3 is a valid target for cachexia treatment [72].